ESMO clinical practice guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation

Annals of Oncology

Volumn 25, Issue , 2014, Pages iii143-iii152

  Cherny, N I ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; LEVOMEPROMAZINE; MIDAZOLAM; MORPHINE; PHENOBARBITAL; PROPOFOL; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT;

ADVANCED CANCER; AGITATION; AGRANULOCYTOSIS; ANESTHESIA LEVEL; ANGIONEUROTIC EDEMA; ANTICHOLINERGIC SYNDROME; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; CONVULSION; DELIRIUM; DIET THERAPY; DISEASE SEVERITY; DISTRESS SYNDROME; DYING; DYSPNEA; EUTHANASIA; EXTRAPYRAMIDAL SYMPTOM; FAMILY COUNSELING; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; HYPOTENSION; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL ETHICS; MOBILIZATION; NAUSEA AND VOMITING; ORTHOSTATIC HYPOTENSION; PATIENT AUTONOMY; PATIENT MONITORING; PATIENT PREFERENCE; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; RASH; REHYDRATION; RESPIRATION DEPRESSION; RESTLESSNESS; SEDATION; STEVENS JOHNSON SYNDROME; TERMINAL CARE; TERMINALLY ILL PATIENT; THROMBOCYTOPENIA; TREATMENT INDICATION; COMPLICATION; MEDICAL SOCIETY; NEOPLASM; PAIN; PALLIATIVE THERAPY; PROGNOSIS; STANDARDS;

HEALTH PLANNING GUIDELINES; HUMANS; HYPNOTICS AND SEDATIVES; NEOPLASMS; PAIN; PALLIATIVE CARE; PROGNOSIS; SOCIETIES, MEDICAL; TERMINAL CARE;

EID: 84911467576     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu238     Document Type: Article

References (130)

1. Wanzer SH, Federman DD, Adelstein SJ et al. The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med 1989; 320: 844-849.
2. Roy DJ. Need they sleep before they die? J Palliat Care 1990; 6: 3-4.
3. Burt RA. The Supreme Court speaks-not assisted suicide but a constitutional right to palliative care. N Engl J Med 1997; 337: 1234-1236.
4. Scanlon C, Fleming C. Ethical issues in caring for the patient with advanced cancer. Nurs Clin North Am 1989; 24: 977-986.
5. President's Commission for the Study of Ethical Problems in Medical and Biomedical and Behavioral Research. Deciding to Forgo Life Sustaining Treatment: Ethical and Legal Issues in Treatment Decisions. US Government Printing Office; Washington, DC 1983.
6. American Medical Association. Good care of the dying patient. Council on Scientific Affairs, American Medical Association. JAMA 1996; 275: 474-478.
7. American Geriatrics Society. The care of dying patients: a position statement from the American Geriatrics Society. AGS Ethics Committee. J Am Geriatr Soc 1995; 43: 577-578.
8. American Pain Society. Principles of Analgesic Use in the Treatment Acute Pain and Chronic Cancer Pain. A Concise Guide to Medical Practice. 3rd edition. Skokie, IL: American Pain Society; 1992.
9. American Pain Society Subcommittee on Quality Assurance Standards. Standards for monitoring quality of analgesic treatment of acute pain and cancer pain. American Pain Society Subcommittee on Quality Assurance Standards. Oncol Nurs Forum 1990; 17: 952-954.
10. Spross JA, McGuire DB, Schmitt RM. Oncology nursing society position paper on cancer pain. Part I. Oncol Nurs Forum 1990; 17: 595-614.
11. Spross JA, McGuire DB, Schmitt RM. Oncology nursing society position paper on cancer pain. Part II. Oncol Nurs Forum 1990; 17: 751-760.
12. American College of Physicians. American College of Physicians Ethics Manual. Third edition. Ann Intern Med 1992; 117: 947-960.
13. Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer 1999; 85: 1849-1858.
14. Salisbury C, Bosanquet N, Wilkinson EK et al. The impact of different models of specialist palliative care on patients' quality of life: a systematic literature review. Palliat Med 1999; 13: 3-17.
15. Higginson IJ, Wade AM, McCarthy M. Effectiveness of two palliative support teams. J Public Health Med 1992; 14: 50-56.
16. Higginson IJ, McGregor AM. The impact of palliative medicine? Palliat Med 1999; 13: 273-274.
17. Peruselli C, Di Giulio P, Toscani F et al. Home palliative care for terminal cancer patients: a survey on the final week of life. Palliat Med 1999; 13: 233-241.
18. Higginson IJ, Hearn J. A multicenter evaluation of cancer pain control by palliative care teams. J Pain Symptom Manage 1997; 14: 29-35.
19. Conill C, Verger E, Henriquez I et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997; 14: 328-331.
20. Storey P. Symptom control in advanced cancer. Semin Oncol 1994; 21: 748-753.
21. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990; 6: 7-15.
22. Johanson GA. Symptom character and prevalence during cancer patients' last days of life. Am J Hosp Palliat Care 1991; 8: 6-8, 18.
23. Kutner JS, Bryant LL, Beaty BL, Fairclough DL. Time course and characteristics of symptom distress and quality of life at the end of life. J Pain Symptom Manage 2007; 34: 227-236.
24. Tranmer JE, Heyland D, Dudgeon D et al. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage 2003; 25: 420-429.
25. Kutner JS, Kassner CT, Nowels DE. Symptom burden at the end of life: hospice providers' perceptions. J Pain Symptom Manage 2001; 21: 473-480.
26. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994; 10: 31-38.
27. Barbera L, Seow H, Howell D et al. Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer 2010; 116: 5767-5776.
28. Chater S, Viola R, Paterson J, Jarvis V. Sedation for intractable distress in the dying-a survey of experts. Palliat Med 1998; 12: 255-269.
29. Teunissen SC, Wesker W, Kruitwagen C et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007; 34: 94-104.
30. Ventafridda V, Ripamonti C, De Conno F et al. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990; 6: 7-11.
31. Fainsinger R, Miller MJ, Bruera E et al. Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991; 7: 5-11.
32. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage 1996; 12: 32-38.
33. Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997; 11: 140-144.
34. Fainsinger RL, Landman W, Hoskings M, Bruera E. Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage 1998; 16: 145-152.
35. Anghelescu DL, Hamilton H, Faughnan LG et al. Pediatric palliative sedation therapy with propofol: recommendations based on experience in children with terminal cancer. J Palliat Med 2012; 15: 1082-1090.
36. Kiman R, Wuiloud AC, Requena ML. End of life care sedation for children. Curr Opin Support Palliat Care 2011; 5: 285-290.
37. Chiu TY, Hu WY, Lue BH et al. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001; 21: 467-472.
38. Muller-Busch HC, Andres I, Jehser T. Sedation in palliative care-a critical analysis of 7 years experience. BMC Palliat Care 2003; 2: 2.
39. Sykes N, Thorns A. Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med 2003; 163: 341-344.
40. Morita T. Differences in physician-reported practice in palliative sedation therapy. Support Care Cancer 2004; 12: 584-592.
41. Kohara H, Ueoka H, Takeyama H et al. Sedation for terminally ill patients with cancer with uncontrollable physical distress. J Palliat Med 2005; 8: 20-25.
42. Vitetta L, Kenner D, Sali A. Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life. Am J Hosp Palliat Care 2005; 22: 465-473.
43. Rietjens JA, van Zuylen L, van Veluw H et al. Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation. J Pain Symptom Manage 2008; 36: 228-234.
44. Maltoni M, Pittureri C, Scarpi E et al. Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol 2009; 20: 1163-1169.
45. Mercadante S, Intravaia G, Villari P et al. Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage 2009; 37: 771-779.
46. Claessens P, Menten J, Schotsmans P, Broeckaert B. Palliative sedation, not slow euthanasia: a prospective, longitudinal study of sedation in Flemish palliative care units. J Pain Symptom Manage 2011; 41: 14-24.
47. Jaspers B, Nauck F, Lindena G et al. Palliative sedation in Germany: how much do we know? A prospective survey. J Palliat Med 2012; 15: 672-680.
48. Maltoni M, Scarpi E, Rosati M et al. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol 2012; 30: 1378-1383.
49. Daly BJ, Thomas D, Dyer MA. Procedures used in withdrawal of mechanical ventilation. Am J Crit Care 1996; 5: 331-338.
50. Campbell ML, Bizek KS, Thill M. Patient responses during rapid terminal weaning from mechanical ventilation: a prospective study. Crit Care Med 1999; 27: 73-77.
51. Wilson WC, Smedira NG, Fink C et al. Ordering and administration of sedatives and analgesics during the withholding and withdrawal of life support from critically ill patients. JAMA 1992; 267: 949-953.
52. Feldman HA, McKinlay JB, Potter DA et al. Nonmedical influences on medical decision making: an experimental technique using videotapes, factorial design, and survey sampling. Health Serv Res 1997; 32: 343-366.
53. Christakis NA, Asch DA. Biases in how physicians choose to withdraw life support. Lancet 1993; 342: 642-646.
54. Back AL, Arnold RM, Baile WF et al. Approaching difficult communication tasks in oncology. CA Cancer J Clin 2005; 55: 164-177.
55. Back AL, Anderson WG, Bunch L et al. Communication about cancer near the end of life. Cancer 2008; 113(7 Suppl): 1897-1910.
56. Sanson-Fisher R, Girgis A, Boyes A et al. The unmet supportive care needs of patients with cancer. Supportive Care Review Group. Cancer 2000; 88: 226-237.
57. Campbell HS, Sanson-Fisher R, Taylor-Brown J et al. The cancer support person's unmet needs survey: psychometric properties. Cancer 2009; 115: 3351-3359.
58. Harrison JD, Young JM, Price MA et al. What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer 2009; 17: 1117-1128.
59. Hack TF, Degner LF, Parker PA. The communication goals and needs of cancer patients: a review. Psycho-oncology 2005; 14: 831-845; discussion 846-847.
60. Thorne SE, Bultz BD, Baile WF. Is there a cost to poor communication in cancer care? A critical review of the literature. Psychooncology 2005; 14: 875-884; discussion 885-886.
61. Helft PR. Necessary collusion: prognostic communication with advanced cancer patients. J Clin Oncol 2005; 23: 3146-3150.
62. Freedman B. Offering truth. One ethical approach to the uninformed cancer patient. Arch Intern Med 1993; 153: 572-576.
63. Meredith C, Symonds P, Webster L et al. Information needs of cancer patients in west Scotland: cross sectional survey of patients' views. BMJ 1996; 313: 724-726.
64. Fleissig A. Information needs of patients with cancer. Patients are frightened and their information needs fluctuate. BMJ 2000; 321: 632; author reply 633.
65. Lockwood S, Manaszewicz R. Information needs of patients with cancer. Patients' perspectives may vary. BMJ 2000; 321: 632-633.
66. Leydon GM, Boulton M, Moynihan C et al. Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ 2000; 320: 909-913.
67. Pinquart M, Duberstein PR. Information needs and decision-making processes in older cancer patients. Critical Rev Oncol Hematol 2004; 51: 69-80.
68. Davison BJ, Degner LF, Morgan TR. Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum 1995; 22: 1401-1408.
69. Stiggelbout AM, Kiebert GM. A role for the sick role. Patient preferences regarding information and participation in clinical decision-making. CMAJ 1997; 157: 383-389.
70. Postovsky S, Moaed B, Krivoy E et al. Practice of palliative sedation in children with brain tumors and sarcomas at the end of life. Pediatr Hematol Oncol 2007; 24: 409-415.
71. Fraser J, Harris N, Berringer AJ et al. Advanced care planning in children with life-limiting conditions-the Wishes Document. Arch Dis Child 2010; 95: 79-82.
72. Cherny NI, Radbruch L. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 2009; 23: 581-593.
73. Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med 1997; 15: 357-365.
74. Burke AL. Palliative care: an update on 'terminal restlessness'. Med J Aust 1997; 166: 39-42.
75. Collins P. Prolonged sedation with midazolam or propofol. Crit Care Med 1997; 25: 556-557.
76. Johanson GA. Midazolam in terminal care. Am J Hosp Palliat Care 1993; 10: 13-14.
77. Power D, Kearney M. Management of the final 24 hours. Ir Med J 1992; 85: 93-95.
78. Burke AL, Diamond PL, Hulbert J et al. Terminal restlessness-its management and the role of midazolam. Med J Aust 1991; 155: 485-487.
79. Oliver DJ. The use of methotrimeprazine in terminal care. Br J Clin Pract 1985; 39: 339-340.
80. O'Neill J, Fountain A. Levomepromazine (methotrimeprazine) and the last 48 hours. Hosp Med 1999; 60: 564-567.
81. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994; 9: 341-345.
82. LeGrand SB. Dyspnea: the continuing challenge of palliative management. Curr Opin Oncol 2002; 14: 394-398.
83. Greene WR, Davis WH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J 1991; 84: 332-337.
84. Truog RD, Berde CB, Mitchell C, Grier HE. Barbiturates in the care of the terminally ill. N Engl J Med 1992; 327: 1678-1682.
85. Tobias JD. Propofol sedation for terminal care in a pediatric patient. Clin Pediatr (Phila) 1997; 36: 291-293.
86. Krakauer EL, Penson RT, Truog RD et al. Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effect. Oncologist 2000; 5: 53-62.
87. Mercadante S, De Conno F, Ripamonti C. Propofol in terminal care. J Pain Symptom Manage 1995; 10: 639-642.
88. Moyle J. The use of propofol in palliative medicine. J Pain Symptom Manage 1995; 10: 643-646.
89. Mercadante S, Porzio G, Valle A et al. Palliative sedation in advanced cancer patients followed at home: a retrospective analysis. J Pain Symptom Manage 2012; 43: 1126-1130.
90. Barathi B. Palliative sedation at home. Indian J Palliat Care 2012; 18: 74-77.
91. Alonso-Babarro A, Varela-Cerdeira M, Torres-Vigil I et al. At-home palliative sedation for end-of-life cancer patients. Palliat Med 2010; 24: 486-492.
92. Rosengarten OS, Lamed Y, Zisling T et al. Palliative sedation at home. J Palliat Care 2009; 25: 5-11.
93. Bishop MF, Stephens L, Goodrich M, Byock I. Medication kits for managing symptomatic emergencies in the home: a survey of common hospice practice. J Palliat Med 2009; 12: 37-44.
94. Falk S, Fallon M. ABC of palliative care. Emergencies. BMJ 1997; 315: 1525-1528.
95. Nauck F, Alt-Epping B. Crises in palliative care-a comprehensive approach. Lancet Oncol 2008; 9: 1086-1091.
96. Rousseau P. Existential distress and palliative sedation. Anesth Analg 2005; 101: 611-612.
97. Taylor BR, McCann RM. Controlled sedation for physical and existential suffering? J Palliat Med 2005; 8: 144-147.
98. Cherny NI. Commentary: sedation in response to refractory existential distress: walking the fine line. J Pain Symptom Manage 1998; 16: 404-406.
99. Miller FG, Fins JJ, Bacchetta MD. Clinical pragmatism: John Dewey and clinical ethics. J Contemp Health Law Policy 1996; 13: 27-51.
100. Fins JJ, Bacchetta MD, Miller FG. Clinical pragmatism: a method of moral problem solving. Kennedy Inst Ethics J 1997; 7: 129-145.
101. Gevers S. Terminal sedation: a legal approach. Eur J Health Law 2003; 10: 359-367.
102. Devlin P. Easing the Passing: The Trial of Dr John Bodkin Adams. London: The Bodley Head; 1985.
103. Brody H. Causing, intending, and assisting death. J Clin Ethics 1993; 4: 112-117.
104. Craig GM. On withholding artificial hydration and nutrition from terminally ill sedated patients. The debate continues. J Med Ethics 1996; 22: 147-153.
105. Craig GM. On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? J Med Ethics 1994; 20: 139-143; discussion 144-145.
106. Craig G. Is sedation without hydration or nourishment in terminal care lawful? Med Leg J 1994; 62(Pt 4): 198-201.
107. Orentlicher D. The Supreme Court and physician-assisted suicide-rejecting assisted suicide but embracing euthanasia. N Engl J Med 1997; 337: 1236-1239.
108. Hahn MP. Review of palliative sedation and its distinction from euthanasia and lethal injection. J Pain Palliat Care Pharmacother 2012; 26: 30-39.
109. Levy MH, Cohen SD. Sedation for the relief of refractory symptoms in the imminently dying: a fine intentional line. Semin Oncol 2005; 32: 237-246.
110. Hasselaar JG, Reuzel RP, van den Muijsenbergh ME et al. Dealing with delicate issues in continuous deep sedation. Varying practices among Dutch medical specialists, general practitioners, and nursing home physicians. Arch Intern Med 2008; 168: 537-543.
111. Kuhse H, Singer P, Baume P et al. End-of-life decisions in Australian medical practice. Med J Aust 1997; 166: 191-196.
112. Stevens CA, Hassan R. Management of death, dying and euthanasia: attitudes and practices of medical practitioners in South Australia. J Med Ethics 1994; 20: 41-46.
113. Willems DL, Daniels ER, van der Wal G et al. Attitudes and practices concerning the end of life: a comparison between physicians from the United States and from The Netherlands. Arch Intern Med 2000; 160: 63-68.
114. Meier DE, Emmons CA, Wallenstein S et al. A national survey of physicianassisted suicide and euthanasia in the United States. N Engl J Med 1998; 338: 1193-1201.
115. Douglas CD, Kerridge IH, Rainbird KJ et al. The intention to hasten death: a survey of attitudes and practices of surgeons in Australia. Med J Aust 2001; 175: 511-515.
116. Rietjens JA, van der Heide A, Vrakking AM et al. Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands. Ann Intern Med 2004; 141: 178-185.
117. Fainsinger RL, De Moissac D, Mancini I, Oneschuk D. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 2000; 16: 5-10.
118. Murray SA, Boyd K, Byock I. Continuous deep sedation in patients nearing death. BMJ 2008; 336: 781-782.
119. Higgins PC, Altilio T. Palliative sedation: an essential place for clinical excellence. J Soc Work End Life Palliat Care 2007; 3: 3-30.
120. Haynes AB, Weiser TG, Berry WR et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009; 360: 491-499.
121. Hoffman GM, Nowakowski R, Troshynski TJ et al. Risk reduction in pediatric procedural sedation by application of an American Academy of Pediatrics/ American Society of Anesthesiologists process model. Pediatrics 2002; 109: 236-243.
122. Dean MM, Cellarius V, Henry B, Oneschuk D. Librach Canadian Society Of Palliative Care Physicians Taskforce SL. Framework for continuous palliative sedation therapy in Canada. J Palliat Med 2012; 15: 870-879.
123. Ghafoor VL, Silus LS. Developing policy, standard orders, and quality-assurance monitoring for palliative sedation therapy. Am J Health Syst Pharm 2011; 68: 523-527.
124. Royal Dutch Medical Association Committee on National Guideline for Palliative Sedation. Guideline for palliative sedation 2005; http://knmg.artsennet.nl/uri/?uri=AMGATE_6059_100_TICH_R193567276369746 (19 June 2014, date last accessed)
125. Verkerk M, van Wijlick E, Legemaate J, de Graeff A. A national guideline for palliative sedation in the Netherlands. J Pain Symptom Manage 2007; 34: 666-670.
126. Morita T, Bito S, Kurihara Y, Uchitomi Y. Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med 2005; 8: 716-729.
127. Hospice and Palliative Care Federation of Massachusetts. Palliative Sedation Protocol: A Report of the Standards and Best Practices Committee. Norwood, MA: Hospice and Palliative Care Federation of Massachusetts 2004.
128. Kirk TW, Mahon MM. National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage 2010; 39: 914-923.
129. National Ethics Committee. The ethics of palliative sedation as a therapy of last resort. Am J Hosp Palliat Care 2006; 23: 483-491.
130. Braun TC, Hagen NA, Clark T. Development of a clinical practice guideline for palliative sedation. J Palliat Med 2003; 6: 345-350.